PARADISE-MI results obscured as post hoc analysis finds flawsSeptember 14, 2022Acute Coronary SyndromesHeart FailureCAD & AtherosclerosisInterventional Cardiology & Surgery
Dietary change tops for reducing CVD risk in stage 1 hypertensionSeptember 13, 2022HypertensionLipid DisordersAcute Coronary SyndromesCAD & AtherosclerosisPreventive Care
‘Spectacular’ polypill results also puzzle docsSeptember 13, 2022Preventive CareCAD & AtherosclerosisHypertensionLipid Disorders
Test Lp(a) levels to inform ASCVD management: NLA statementSeptember 12, 2022Lipid DisordersCAD & AtherosclerosisAcute Coronary Syndromes
No invasive strategy benefit at 5 years in ISCHEMIA-CKD extension studySeptember 9, 2022Interventional Cardiology & SurgeryAcute Coronary SyndromesCAD & AtherosclerosisImagingLipid Disorders
ACC/AHA issue chest pain data standards update to 2021 guidelineSeptember 9, 2022Acute Coronary SyndromesCAD & AtherosclerosisInterventional Cardiology & Surgery
Artificial sweeteners linked to higher CV event riskSeptember 9, 2022Interventional Cardiology & SurgeryAcute Coronary SyndromesCAD & AtherosclerosisHeart FailureHypertensionLipid DisordersStroke
Low physical function tied to cardiac events in older adultsSeptember 6, 2022CAD & AtherosclerosisHeart FailureStroke
Majority of muscle symptoms with statins not caused by treatmentAugust 31, 2022Lipid DisordersCAD & AtherosclerosisMixed Topics
Evolocumab benefits accrue with longer follow-up: FOURIER OLEAugust 31, 2022Lipid DisordersInterventional Cardiology & SurgeryAcute Coronary SyndromesCAD & AtherosclerosisDiabetes
ACC fills gaps on guidance for nonstatin therapies for LDL-C loweringAugust 29, 2022Lipid DisordersCAD & AtherosclerosisAcute Coronary Syndromes
No benefit of routine stress test POST-PCI in high-risk patientsAugust 28, 2022Interventional Cardiology & SurgeryImagingAcute Coronary SyndromesCAD & Atherosclerosis
AXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in strokeAugust 28, 2022StrokeThrombosisCAD & AtherosclerosisLipid DisordersHypertension
